Conversio Health Recalls Albuterol and Ipratropium Inhalation Vials
Conversio Health is recalling Albuterol, Ipratropium, and Triamcinolone inhalation vials due to a lack of processing controls.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The FDA classified this recall as Class II, which typically corresponds to a Moderate severity score when no specific hospitalizations or serious injuries are reported in the source text.
Plain-English summary
Integrated Health Concepts Inc. dba Conversio Health is recalling Albuterol 2.5mg / Ipratropium 0.75mg / Triamcinolone 0.5 mg 3ML Vials, For Inhalation Only. The recall is being conducted because of a lack of processing controls. The product is distributed nationwide in the U.S. and includes all lots.
The FDA has classified this recall as Class II. This classification indicates that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
Consumers should stop using the recalled product and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- Albuterol 2.5mg / Ipratropium 0.75mg/ Triamcinolone 0.5 mg 3ML Vial, For Inhalation Only, Conversio Health, San Luis Obispo, CA 93401.
- Category
- Drug — Inhalation Medication
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 10 recalled by Integrated Health Concepts Inc. dba Conversio Health under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 10 products in this recall →Related recalls
Same manufacturer · Integrated Health Concepts Inc. dba Conversio Health
See all →- ModerateConversio Health Recalls Budesonide Inhalation Vials Due to Processing Control Issues
FDA (Drugs) · 2019-11-27
- ModerateConversio Health Recalls Albuterol and Ipratropium Inhalation Vials
FDA (Drugs) · 2019-11-27
- ModerateConversio Health Recalls Albuterol and Ipratropium Vials Due to Processing Controls
FDA (Drugs) · 2019-11-27
- ModerateConversio Health Recalls Albuterol and Ipratropium Vials Due to Processing Controls
FDA (Drugs) · 2019-11-27
- ModerateConversio Health Recalls Albuterol, Ipratropium, and Budesonide Inhalation Vials
FDA (Drugs) · 2019-11-27
Same hazard · processing controls
See all →- HighCompounded tirzepatide 8.8 mg vials recalled over lack of processing controls
FDA (Drugs) · 2025-08-13
- HighCompounded tirzepatide 11.24 mg vials recalled over lack of processing controls
FDA (Drugs) · 2025-08-13
- HighCompounded semaglutide 0.22 mg vials recalled over lack of processing controls
FDA (Drugs) · 2025-08-13
- HighCompounded semaglutide 0.44 mg vials recalled over lack of processing controls
FDA (Drugs) · 2025-08-13
- HighCompounded tirzepatide 4.4 mg vials recalled over lack of processing controls
FDA (Drugs) · 2025-08-13